Literature DB >> 10933636

Chronic prostatitis-an infectious disease?

K G Naber1, W Weidner.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10933636     DOI： 10.1093/jac/46.2.157

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  16 in total

Review 1.  Inflammation and benign prostatic hyperplasia: clinical implications.

Authors:  Bilal Chughtai; Richard Lee; Alexis Te; Steven Kaplan
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

2.  Role of inflammation in benign prostatic hyperplasia.

Authors:  Bilal Chughtai; Richard Lee; Alexis Te; Steven Kaplan
Journal:  Rev Urol       Date:  2011

3.  Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).

Authors:  Irene Paterniti; Michela Campolo; Marika Cordaro; Rosalba Siracusa; Antonio Filippone; Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Inflamm Res       Date:  2018-04-20       Impact factor: 4.575

4.  Peripheral mononuclear leukocyte DNA damage, plasma prolidase activity, and oxidative status in patients with benign prostatic hyperplasia.

Authors:  Ilhan Gecit; Ismail Meral; Mehmet Aslan; Abdurrahim Kocyigit; Hakim Celik; Abdullah Taskın; Mehmet Kaba; Necip Pirincci; Mustafa Gunes; Kerem Taken; Halit Demir; Mehmet Uyuklu; Kadir Ceylan
Journal:  Redox Rep       Date:  2014-12-31       Impact factor: 4.412

5.  Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.

Authors:  Felipe K Hurtado; Benjamin Weber; Hartmut Derendorf; Guenther Hochhaus; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

6.  A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Jianxin Wang; Dongliang Yan; Kuixiang Liang; Zhonghua Xu
Journal:  Int Urol Nephrol       Date:  2015-11-17       Impact factor: 2.370

Review 7.  Oxidative stress in prostate cancer.

Authors:  Lakshmipathi Khandrika; Binod Kumar; Sweaty Koul; Paul Maroni; Hari K Koul
Journal:  Cancer Lett       Date:  2009-01-30       Impact factor: 8.679

8.  Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases?

Authors:  Chukwunonso E C C Ejike; Lawrence U S Ezeanyika
Journal:  Int Urol Nephrol       Date:  2008-02-21       Impact factor: 2.370

Review 9.  Chronic pelvic pain syndrome and the overactive bladder: the inflammatory link.

Authors:  Rajiv Saini; Ricardo R Gonzalez; Alexis E Te
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

10.  Application of real-time polymerase chain reaction technology to detect prostatic bacteria in patients with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Satoshi Takahashi; Donald E Riley; John N Krieger
Journal:  World J Urol       Date:  2003-05-13       Impact factor: 4.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.